Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-24 @ 2:06 PM
NCT ID:
NCT05640895
Eligibility Criteria:
Inclusion Criteria:
* Age 18 -100 years
* Diagnosis of diabetic macular edema, age related macular degeneration, or retinal vein occlusion
* Treated with bevacizumab, ranibizumab, aflibercept
* The need for at least two intravitreal injections
* Pseudophakia
Exclusion Criteria:
* Texas Department of Corrections medical records
* Under 18 years-of-age
* First intravitreal injection experience of patient
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05640895
Study Brief:
Protocol Section:
NCT05640895